WGC
DXCM icon

Watts Gwilliam & Co’s DexCom DXCM Stock Holding History

Watts Gwilliam & Co’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$2.47M Buy
36,746
+200
+0.5% +$15.8K 0.4% 47
2025
Q2 		$2.77M Sell
36,546
-8,275
-18% -$649K 0.45% 44
2025
Q1 		$3.06M Buy
44,821
+2,800
+7% +$228K 0.66% 37
2024
Q4 		$3.33M Buy
+42,021
New +$3.11M 0.7% 34

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Watts Gwilliam & Co's DXCM Position: Q3 2025 in Review

Watts Gwilliam & Co increased its DexCom (DXCM) stake by 0.55% in Q3 2025, buying an estimated $15.8K and bringing the position to 36,746 shares worth $2.47M. The position accounts for 0.4% of the portfolio, ranked #47.

Watts Gwilliam & Co first reported a position in DXCM in Q4 2024 and has held it in 4 quarters since. The position peaked at $3.33M in Q4 2024. 910 funds tracked by Wall St. Rank hold DXCM as of Q3 2025.

  • Watts Gwilliam & Co held 36,746 shares of DexCom worth $2.47M as of Q3 2025.
  • Watts Gwilliam & Co bought 200 DexCom shares in Q3 2025, an estimated $15.8K.
  • DexCom made up 0.4% of Watts Gwilliam & Co's portfolio in Q3 2025, its #47 holding.
  • Watts Gwilliam & Co first reported a position in DexCom in Q4 2024 and has held it in 4 quarters since.
  • Watts Gwilliam & Co's DexCom position peaked at $3.33M in Q4 2024.
  • 910 funds tracked by Wall St. Rank held DexCom as of Q3 2025.

Based on Watts Gwilliam & Co's 13F filing for Q3 2025, filed 21 Nov 2025.